The MUP-uPA mouse model of NASH-HCC relies on both a high fat diet and the overexpression and ER accumulation of urokinase plasminogen activator (uPA) in the hepatocytes for tumorigenesis (Febbraio et al., 2019). The gene discussed is PLAU; the disease is metabolic dysfunction-associated steatohepatitis.